Related references
Note: Only part of the references are listed.Standalone operation of an EGOFET for ultra-sensitive detection of HIV
Sunil Kumar Sailapu et al.
BIOSENSORS & BIOELECTRONICS (2020)
Peptide-modified electrolyte-gated organic field effect transistor. Application to Cu2+ detection
T. T. K. Nguyen et al.
BIOSENSORS & BIOELECTRONICS (2019)
Label free detection of plant viruses with organic transistor biosensors
Marcello Berto et al.
SENSORS AND ACTUATORS B-CHEMICAL (2019)
Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors
Milena Tocut et al.
AUTOIMMUNITY REVIEWS (2018)
Triggering the Electrolyte-Gated Organic Field-Effect Transistor output characteristics through gate functionalization using diazonium chemistry: Application to biodetection of 2,4-dichlorophenoxyacetic acid
T. T. K. Nguyen et al.
BIOSENSORS & BIOELECTRONICS (2018)
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab
B. Gorovits et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)
Single-molecule detection with a millimetre-sized transistor
Eleonora Macchia et al.
NATURE COMMUNICATIONS (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in PatientsWith Metastatic Solid Tumors
Shruti Agrawal et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Nivolumab as Programmed Death-1 (PD-1) Inhibitor for Targeted Immunotherapy in Tumor
Liting Guo et al.
JOURNAL OF CANCER (2017)
Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis
Adam K. Karlsson et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2017)
Biorecognition in Organic Field Effect Transistors Biosensors: The Role of the Density of States of the Organic Semiconductor
Marcello Berto et al.
ANALYTICAL CHEMISTRY (2016)
PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis
Sara Gandini et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges
Emilie M. J. van Brummelen et al.
ONCOLOGIST (2016)
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
Patrick J. Medina et al.
PHARMACOTHERAPY (2016)
Electrolytic Gated Organic Field-Effect Transistors for Application in Biosensors-A Review
Denjung Wang et al.
ELECTRONICS (2016)
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
Kathleen M. Mahoney et al.
CLINICAL THERAPEUTICS (2015)
Nivolumab: A Review in Advanced Melanoma
Lesley J. Scott
DRUGS (2015)
Immune Checkpoint Blockade in Cancer Therapy
Michael A. Postow et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Combined immunotherapy-a new standard in metastatic melanoma?
Axel Hauschild et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
Changyu Wang et al.
CANCER IMMUNOLOGY RESEARCH (2014)
DNA detection with a water-gated organic field-effect transistor
Loig Kergoat et al.
ORGANIC ELECTRONICS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The PDL1-PD1 Axis Converts Human TH1 Cells into Regulatory T Cells
Shoba Amarnath et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Clinical and biological consequences of immunization to infliximab in pediatric Crohn's disease
S Candon et al.
CLINICAL IMMUNOLOGY (2006)
Share Paper
